Please wait a minute...
Shopping Cart Email List Chinese
Advanced Search Fig/Tab
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Featured Articles  |  Most Downloaded  |  Most Reading
Online Submission Subscribe to Our RSS Content Feed
Front Med    0, Vol. Issue () : 322-328    https://doi.org/10.1007/s11684-012-0204-8
RESEARCH ARTICLE
Obesity and overweight prevalence and its association with undiagnosed hypertension in Shanghai population, China: a cross-sectional population-based survey
Xinjian Li(), Jiying Xu, Haihong Yao, Yanfei Guo, Minna Chen, Wei Lu()
Department of Cardiovascular Disease Control and Prevention, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai 200336, China
 Download: PDF(109 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

The aim of this study was to determine the prevalence of overweight and obese subjects in the Shanghai population of China and its association with undiagnosed hypertension, by taking age, gender and place of residence (urban or suburban) into account. A cross-sectional population-based survey was conducted in 2007. The sample included 13 359 participants aged 15–69 years. Weight, height, and blood pressure were recorded, and information about gender, age and place of residence was obtained. Overweight and obesity prevalence were calculated by the body mass index (BMI) definition recommended by Working Group on Obesity in China (normal weight, 18.5–23.9 kg/m2; overweight, 24–27.9 kg/m2; obesity,≥28 kg/m2). Undiagnosed hypertension was defined by China criteria in accord with that of WHO-ISH (subjects with systolic pressure≥140 mmHg, and/or diastolic pressure≥90 mmHg). Multiple logistic regression analyses were used to assess the association of overweight or obesity with undiagnosed hypertension by adjusting for age, gender and place of residence. The overall overweight, obesity, and undiagnosed hypertension prevalence were 27.6% (95% CI: 26.8–28.4), 6.6% (95% CI: 6.2–7.0), and 15.5% (95% CI: 14.9–16.1), respectively. Compared to normal weight subjects, the odds ratios (OR) for subjects who were overweight and had hypertension was 2.33 (95% CI: 2.10–2.59); that for obesity and hypertension was 4.27 (95% CI: 3.66–4.99). These data suggest that overweight and obesity prevalence and their association with undiagnosed hypertension are high in our study population.
Keywords overweight      obesity      undiagnosed hypertension      prevalence      association     
Corresponding Author(s): Li Xinjian,Email:xjli@scdc.sh.cn; Lu Wei,Email:weiloo@scdc.sh.cn   
Issue Date: 05 September 2012
 Cite this article:   
Yanfei Guo,Minna Chen,Xinjian Li, et al. Obesity and overweight prevalence and its association with undiagnosed hypertension in Shanghai population, China: a cross-sectional population-based survey[J]. Front Med, 0, (): 322-328.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-012-0204-8
https://academic.hep.com.cn/fmd/EN/Y0/V/I/322
Age group (year)NMenWomenTotal
OverweightObesityOverweightObesityOverweightObesity
nnnnnn
% (95% CI)% (95% CI)% (95% CI)% (95% CI)% (95% CI)% (95% CI)
15–241 71813747903322780
17.9 (15.2–20.6)6.2 (4.4–8.0)9.4 (7.6–11.2)3.5 (2.3–4.7)13.2 (11.6–14.8)4.7 (3.7–5.7)
25–341 892212361033031566
23.8 (21.1–26.5)4.0 (2.6–5.4)10.3 (8.3–12.3)3.0 (2.0–4.0)16.6 (14.8–18.4)3.5 (2.7–4.3)
35–442 2223536029173644133
34.1 (31.2–37.0)5.8 (4.4–7.2)24.5 (22.1–26.9)6.1 (4.7–7.5)29.0 (27.0–31.0)6.0 (5.0–7.0)
45–544 1466901056651651 355270
34.3 (32.1–36.5)5.2 (4.2–6.2)31.1 (29.1–33.1)7.7 (6.5–8.9)32.7 (31.3–34.1)6.5 (5.7–7.3)
55–642 73843597516171951268
33.2 (30.7–35.7)7.4 (6.0–8.8)36.1 (33.6–38.6)12.0 (10.2–13.8)34.7 (32.9–36.5)9.8 (8.6–11.0)
65–6964381191104219161
28.7 (23.4–34.0)6.7 (3.8–9.6)30.5 (25.8–35.2)11.6 (8.3–14.9)29.7 (26.2–33.2)9.5 (7.1–11.9)
All13 3591 9083641 7755143 683878
30.3 (29.1–31.5)5.8 (5.2–6.4)25.1 (24.1–26.1)7.3 (6.7–7.9)27.6 (26.8–28.4)6.6 (6.2–7.0)
Standardized29.35.723.56.826.26.3
Tab.1  Age and gender stratified overweight and obesity prevalence among subjects of Shanghai, China
Age group (year)MenWomenTotal
NNN
% (95% CI)% (95% CI)% (95% CI)
15–24422365
5.5 (3.9–7.1)2.4 (1.4–3.4)3.8 (2.8–4.8)
25–346739106
7.5 (5.7–9.3)3.9 (2.2–4.6)5.6 (4.6–6.6)
35–44143115258
13.8 (11.8–15.8)9.7 (7.9–11.5)11.6 (10.2–13.0)
45–54360347707
17.9 (16.1–19.7)16.3 (14.7–17.9)17.1 (15.9–18.3)
55–64345353698
26.4 (24.0–28.8)24.7 (22.5–26.9)25.5 (23.9–27.1)
65–69114124238
40.4 (34.7–46.1)34.4 (29.5–39.3)37.0 (33.3–40.7)
All1 0711 0012 072
17.0 (16.0–18.0)14.2 (13.4–15.0)15.5 (14.9–16.1)
Standardized15.712.814.2
Tab.2  Age and gender stratified undiagnosed hypertension prevalence among 13 359 residents of Shanghai, China
Risk factorOverweightObesity
Prevalence (%)OR95% CIP-valuePrevalence (%)OR95% CIP-value
Age(year)
15–2413.21(Ref)4.71(Ref)
25–3416.61.291.07–1.550.0073.50.760.54–1.06NS
35–4429.02.632.22–3.11<0.0016.01.351.01–1.790.042
45–5432.73.162.71–3.68<0.0016.51.451.12–1.870.005
55–6434.73.452.94–4.05<0.0019.82.271.75–2.94<0.001
65–6929.72.762.22–3.44<0.0019.52.171.54–3.07<0.001
Gender
?Women25.11(Ref)7.31(Ref)
Men30.31.291.20–1.40<0.0015.80.780.68–0.90<0.001
Area
Urban26.51(Ref)7.01(Ref)
Suburban28.61.101.02–1.190.0156.20.880.77–1.01NS
Tab.3  Overweight and obesity prevalence and adjusted of potential risk factors in residents
Risk factorPrevalence (%)OR95% CIP-value
Normal-weight11.21(Ref)
Overweight22.72.332.10–2.59<0.001
Obesity35.04.273.66–4.99<0.001
Tab.4  Undiagnosed hypertension prevalence and adjusted effects of overweight and obesity on residents
1 World Health Organization. http://www.wpro.who.int/health_topics/obesity (Accessed on February11, 2011)
2 Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45(1): 9–14
pmid:15583075
3 Leenen FH, McInnis NH, Fodor G. Obesity and the prevalence and management of hypertension in Ontario, Canada. Am J Hypertens 2010; 23(9): 1000–1006
doi: 10.1038/ajh.2010.93 pmid:20448534
4 Liu L. Cardiovascular diseases in China. Biochem Cell Biol 2007; 85(2): 157–163
doi: 10.1139/O07-004 pmid:17534394
5 World Health Organization. The world Health Report 2002. Geneva: World Health Organization, 2003
6 Popkin BM, Kim S, Rusev ER, Du S, Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev 2006; 7(3): 271–293
doi: 10.1111/j.1467-789X.2006.00230.x pmid:16866975
7 Popkin BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 2006; 84(2): 289–298
pmid:16895874
8 Zhao W, Zhai Y, Hu J, Wang J, Yang Z, Kong L, Chen C. Economic burden of obesity-related chronic diseases in Mainland China. Obes Rev 2008; 9(Suppl 1): 62–67
doi: 10.1111/j.1467-789X.2007.00440.x pmid:18307701
9 Ma GS, Li YP, Wu YF, Zhai FY, Cui ZH, Hu XQ, Luan DC, Hu YH, Yang XG. The prevalence of body overweight and obesity and its changes among Chinese people during 1992 to 2002. Chin J Prev Med (Zhonghua Yu Fang Yi Xue Za Zhi) 2005; 39(5): 311–315 (in Chinese)
pmid:16266539
10 WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403): 157–163
doi: 10.1016/S0140-6736(03)15268-3 pmid:14726171
11 Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002; 3(3): 141–146
doi: 10.1046/j.1467-789X.2002.00065.x pmid:12164465
12 Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN Jr. Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 1994; 60(1): 23–28
pmid:8017333
13 World Health Organization. Obesity: Preventing and Managing the Golobal Epdemic. Geneva: World Health Organization, 1997
14 Allman-Farinelli MA, Chey T, Bauman AE, Gill T, James WP. Age, period and birth cohort effects on prevalence of overweight and obesity in Australian adults from 1990 to 2000. Eur J Clin Nutr 2008; 62(7): 898–907
doi: 10.1038/sj.ejcn.1602769 pmid:17440514
15 Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004; 286(5): R803–R813
doi: 10.1152/ajpregu.00707.2003 pmid:15068965
16 Nguyen TT, Adair LS, Suchindran CM, He K, Popkin BM. The association between body mass index and hypertension is different between East and Southeast Asians. Am J Clin Nutr 2009; 89(6): 1905–1912
doi: 10.3945/ajcn.2008.26809 pmid:19369374
17 Chen CM, Kong LZ. Guideline for Prevention and Control of Overweight and Obesity in Adult. Beijing: People’s Medical Publishing House, 2006
18 Revision Committee of China Guideline for Prevention and Treatment of Hypertension in Adult. China Guideline for Prevention and Treatment of Hypertension in Adult . Beijing: People’s Medical Publishing House, 2005
19 Shanghai Municipal Statistics Bureau. Shanghai Statistical Yearbook 2007. Beijing: China Statistics Press, 2007
20 Cooperartive Meta-analysis Group of the Working Group on Obesity in China. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases—report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci 2002; 15(3): 245–252
pmid:12500665
21 Nguyen TT, Adair LS, He K, Popkin BM. Optimal cutoff values for overweight: using body mass index to predict incidence of hypertension in 18- to 65-year-old Chinese adults. J Nutr 2008; 138(7): 1377–1382
pmid:18567764
22 Cooperartive Meta-analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002; 15(1): 83–96
pmid:12046553
23 Wu YF, Ma GS, Hu YH, Li YP, Li X, Cui ZH, Chen CM, Kong LZ. The current prevalence status of body overweight and obesity in China: data from the China National Nutrition and Health Survey. Chin J Prev Med (Zhonghua Yu Fang Yi Xue Za Zhi) 2005; 39(5): 316–320 (in Chinese)
pmid:16266540
24 Chen J, Zhao XL, Wu F, Cui YL, Hu DY. Epidemiology of obesity and overweight and relation thereof to the prevalence of hypertension in 14 provinces/municipality in China. Natl Med J China (Zhonghua Yi Xue Za Zhi) 2005; 85(40): 2830–2834 (in Chinese)
pmid:16324340
25 Martínez-Ros MT, Tormo MJ, Navarro C, Chirlaque MD, Pérez-Flores D. Extremely high prevalence of overweight and obesity in Murcia, a Mediterranean region in south-east Spain. Int J Obes Relat Metab Disord 2001; 25(9): 1372–1380
doi: 10.1038/sj.ijo.0801684 pmid:11571602
26 Cea-Calvo L, Moreno B, Monereo S, Gil-Guillén V, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J, González-Esteban J, Redón J; PREV-ICTUS Study.Prevalence and related factors of overweight and obesity in Spanish population aged 60 years-old or older. The PREV-ICTUS study. Med Clin (Barc) 2008; 131(6): 205–210
doi: 10.1157/13124609 pmid:18674498
27 Yin R, Wu J, Pan S, Lin W, Yang D, Chen Y. Sex differences in environmental and genetic factors for hypertension. Am J Med 2008; 121(9): 811–819
doi: 10.1016/j.amjmed.2008.04.026 pmid:18724972
28 Silventoinen K, Magnusson PK, Neovius M, Sundstr?m J, Batty GD, Tynelius P, Rasmussen F. Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men. Circulation 2008; 118(16): 1637–1642
doi: 10.1161/CIRCULATIONAHA.108.772707 pmid:18824645
29 Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23(11): 1170–1178
doi: 10.1038/ajh.2010.172 pmid:20706196
30 Stanner S. Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factor. Oxford: Blackwell Publishing, 2005
31 De Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, Perez Castrillon JL. Effects of lifestyle modification on adipocytokine levels in obese patients. Eur Rev Med Pharmacol Sci 2008; 12(1): 33–39
pmid:18401970
32 Cui Z, Huxley R, Wu Y, Dibley MJ. Temporal trends in overweight and obesity of children and adolescents from nine Provinces in China from 1991–2006. Int J Pediatr Obes 2010; 5(5): 365–374
doi: 10.3109/17477166.2010.490262 pmid:20836722
33 The NS, Suchindran C, North KE, Popkin BM, Gordon-Larsen P. Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 2010; 304(18): 2042–2047
doi: 10.1001/jama.2010.1635 pmid:21063014
34 Movahed MR, Bates S, Strootman D, Sattur S. Obesity in adolescence is associated with left ventricular hypertrophy and hypertension. Echocardiography 2011; 28(2): 150–153
doi: 10.1111/j.1540-8175.2010.01289.x pmid:21276070
[1] Chuansong Quan, Zhenjie Zhang, Guoyong Ding, Fengwei Sun, Hengxia Zhao, Qinghua Liu, Chuanmin Ma, Jing Wang, Liang Wang, Wenbo Zhao, Jinjie He, Yu Wang, Qian He, Michael J. Carr, Dayan Wang, Qiang Xiao, Weifeng Shi. Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic[J]. Front. Med., 2022, 16(6): 984-990.
[2] Yalin Liu, Xianghang Luo. New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation[J]. Front. Med., 2022, 16(1): 17-24.
[3] Lingli Cai, Jun Yin, Xiaojing Ma, Yifei Mo, Cheng Li, Wei Lu, Yuqian Bao, Jian Zhou, Weiping Jia. Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial[J]. Front. Med., 2021, 15(3): 460-471.
[4] Na Qin, Yuancheng Li, Cheng Wang, Meng Zhu, Juncheng Dai, Tongtong Hong, Demetrius Albanes, Stephen Lam, Adonina Tardon, Chu Chen, Gary Goodman, Stig E. Bojesen, Maria Teresa Landi, Mattias Johansson, Angela Risch, H-Erich Wichmann, Heike Bickeboller, Gadi Rennert, Susanne Arnold, Paul Brennan, John K. Field, Sanjay Shete, Loic Le Marchand, Olle Melander, Hans Brunnstrom, Geoffrey Liu, Rayjean J. Hung, Angeline Andrew, Lambertus A. Kiemeney, Shan Zienolddiny, Kjell Grankvist, Mikael Johansson, Neil Caporaso, Penella Woll, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Victoria L. Stevens, Guangfu Jin, David C. Christiani, Zhibin Hu, Christopher I. Amos, Hongxia Ma, Hongbing Shen. Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma[J]. Front. Med., 2021, 15(2): 275-291.
[5] So Jung Yang, Hun-Sung Kim, Kun-Ho Yoon. Analyzing the distinguishing factors that affect childhood obesity in South Korea[J]. Front. Med., 2018, 12(6): 707-716.
[6] Tiange Wang, Min Xu, Yufang Bi, Guang Ning. Interplay between diet and genetic susceptibility in obesity and related traits[J]. Front. Med., 2018, 12(6): 601-607.
[7] Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota[J]. Front. Med., 2018, 12(6): 645-657.
[8] Eun Young Lee, Kun-Ho Yoon. Epidemic obesity in children and adolescents: risk factors and prevention[J]. Front. Med., 2018, 12(6): 658-666.
[9] Meng Dong, Jun Lin, Wonchung Lim, Wanzhu Jin, Hyuek Jong Lee. Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia[J]. Front. Med., 2018, 12(2): 130-138.
[10] N.V. Vasilyeva, E.R. Raush, M.V. Rudneva, T.S. Bogomolova, A.E. Taraskina, Yong Fang, Fengmin Zhang, N.N. Klimko. Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey[J]. Front. Med., 2018, 12(1): 84-91.
[11] Tianhua Xu, Zitong Sheng, Li Yao. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment[J]. Front. Med., 2017, 11(3): 340-348.
[12] Rahim Ullah, Yan Su, Yi Shen, Chunlu Li, Xiaoqin Xu, Jianwei Zhang, Ke Huang, Naveed Rauf, Yang He, Jingjing Cheng, Huaping Qin, Yu-Dong Zhou, Junfen Fu. Postnatal feeding with high-fat diet induces obesity and precocious puberty in C57BL/6J mouse pups: a novel model of obesity and puberty[J]. Front. Med., 2017, 11(2): 266-276.
[13] Wei Wang,Ming Li,Li Wang,Xueqing Yu. DQB1*060101 may contribute to susceptibility to immunoglobulin A nephropathy in southern Han Chinese[J]. Front. Med., 2016, 10(4): 507-516.
[14] Jiangbo Du, Wenjie Xue, Yong Ji, Xun Zhu, Yayun Gu, Meng Zhu, Cheng Wang, Yong Gao, Juncheng Dai, Hongxia Ma, Yue Jiang, Jiaping Chen, Zhibin Hu, Guangfu Jin, Hongbing Shen. U-shaped association between telomere length and esophageal squamous cell carcinoma risk: a case-control study in Chinese population[J]. Front. Med., 2015, 9(4): 478-486.
[15] Lixia Gan,Wei Xiang,Bin Xie,Liqing Yu. Molecular mechanisms of fatty liver in obesity[J]. Front. Med., 2015, 9(3): 275-287.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed